149 related articles for article (PubMed ID: 15093816)
1. New radioiodinated carboxylic and hydroxamic matrix metalloproteinase inhibitor tracers as potential tumor imaging agents.
Oltenfreiter R; Staelens L; Lejeune A; Dumont F; Frankenne F; Foidart JM; Slegers G
Nucl Med Biol; 2004 May; 31(4):459-68. PubMed ID: 15093816
[TBL] [Abstract][Full Text] [Related]
2. Tryptophane-based biphenylsulfonamide matrix metalloproteinase inhibitors as tumor imaging agents.
Oltenfreiter R; Staelens L; Labied S; Kersemans V; Frankenne F; Noël A; Van de Wiele C; Slegers G
Cancer Biother Radiopharm; 2005 Dec; 20(6):639-47. PubMed ID: 16398616
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, radiosynthesis, in vitro and preliminary in vivo evaluation of biphenyl carboxylic and hydroxamic matrix metalloproteinase (MMP) inhibitors as potential tumor imaging agents.
Oltenfreiter R; Staelens L; Hillaert U; Heremans A; Noël A; Frankenne F; Slegers G
Appl Radiat Isot; 2005 Jun; 62(6):903-13. PubMed ID: 15799868
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and preliminary biological evaluation of new radioiodinated MMP inhibitors for imaging MMP activity in vivo.
Kopka K; Breyholz HJ; Wagner S; Law MP; Riemann B; Schröer S; Trub M; Guilbert B; Levkau B; Schober O; Schäfers M
Nucl Med Biol; 2004 Feb; 31(2):257-67. PubMed ID: 15013492
[TBL] [Abstract][Full Text] [Related]
5. Targeting of gelatinase activity with a radiolabeled cyclic HWGF peptide.
Kuhnast B; Bodenstein C; Haubner R; Wester HJ; Senekowitsch-Schmidtke R; Schwaiger M; Weber WA
Nucl Med Biol; 2004 Apr; 31(3):337-44. PubMed ID: 15028246
[TBL] [Abstract][Full Text] [Related]
6. Valine-based biphenylsulphonamide matrix metalloproteinase inhibitors as tumor imaging agents.
Oltenfreiter R; Staelens L; Kersemans V; Cornelissen B; Frankenne F; Foidart JM; Van de Wiele C; Slegers G
Appl Radiat Isot; 2006 Jun; 64(6):677-85. PubMed ID: 16546398
[TBL] [Abstract][Full Text] [Related]
7. Comparative studies of potential cancer biomarkers carbon-11 labeled MMP inhibitors (S)-2-(4'-[11C]methoxybiphenyl-4-sulfonylamino)-3-methylbutyric acid and N-hydroxy-(R)-2-[[(4'-[11C]methoxyphenyl)sulfonyl]benzylamino]-3-methylbutanamide.
Zheng QH; Fei X; Liu X; Wang JQ; Stone KL; Martinez TD; Gay DJ; Baity WL; Miller KD; Sledge GW; Hutchins GD
Nucl Med Biol; 2004 Jan; 31(1):77-85. PubMed ID: 14741572
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and in vitro and in vivo evaluation of three radioiodinated nitroimidazole analogues as tumor hypoxia markers.
Li Z; Chu T; Liu X; Wang X
Nucl Med Biol; 2005 Apr; 32(3):225-31. PubMed ID: 15820757
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, biodistribution and micro-PET imaging of a potential cancer biomarker carbon-11 labeled MMP inhibitor (2R)-2-[[4-(6-fluorohex-1-ynyl)phenyl]sulfonylamino]-3-methylbutyric acid [11C]methyl ester.
Zheng QH; Fei X; DeGrado TR; Wang JQ; Stone KL; Martinez TD; Gay DJ; Baity WL; Mock BH; Glick-Wilson BE; Sullivan ML; Miller KD; Sledge GW; Hutchins GD
Nucl Med Biol; 2003 Oct; 30(7):753-60. PubMed ID: 14499334
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of (131/123)I-5-iodo-2'-deoxycytidine as a novel proliferation probe in a tumor mouse model.
Chang WY; Kuo WT; Wu CY; Lin CY; Chan PC; Shen CC; Liu RS; Wang HE; Chen CL
Appl Radiat Isot; 2013 Jul; 77():166-73. PubMed ID: 23602704
[TBL] [Abstract][Full Text] [Related]
11. Chemical design of a radiolabeled gelatinase inhibitor peptide for the imaging of gelatinase activity in tumors.
Hanaoka H; Mukai T; Habashita S; Asano D; Ogawa K; Kuroda Y; Akizawa H; Iida Y; Endo K; Saga T; Saji H
Nucl Med Biol; 2007 Jul; 34(5):503-10. PubMed ID: 17591550
[TBL] [Abstract][Full Text] [Related]
12. A dual inhibitor of matrix metalloproteinases and a disintegrin and metalloproteinases, [¹⁸F]FB-ML5, as a molecular probe for non-invasive MMP/ADAM-targeted imaging.
Matusiak N; Castelli R; Tuin AW; Overkleeft HS; Wisastra R; Dekker FJ; Prély LM; Bischoff R; van Waarde A; Dierckx RA; Elsinga PH
Bioorg Med Chem; 2015 Jan; 23(1):192-202. PubMed ID: 25438884
[TBL] [Abstract][Full Text] [Related]
13. Tumor targeting of MMP-2/9 activatable cell-penetrating imaging probes is caused by tumor-independent activation.
van Duijnhoven SM; Robillard MS; Nicolay K; Grüll H
J Nucl Med; 2011 Feb; 52(2):279-86. PubMed ID: 21233187
[TBL] [Abstract][Full Text] [Related]
14. Preclinical Evaluation of RYM1, a Matrix Metalloproteinase-Targeted Tracer for Imaging Aneurysm.
Toczek J; Ye Y; Gona K; Kim HY; Han J; Razavian M; Golestani R; Zhang J; Wu TL; Jung JJ; Sadeghi MM
J Nucl Med; 2017 Aug; 58(8):1318-1323. PubMed ID: 28360209
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of (E)-3-styrylpyridine derivatives as amyloid imaging agents for Alzheimer's disease.
Ono M; Haratake M; Nakayama M; Kaneko Y; Kawabata K; Mori H; Kung MP; Kung HF
Nucl Med Biol; 2005 May; 32(4):329-35. PubMed ID: 15878502
[TBL] [Abstract][Full Text] [Related]
16. Improved synthesis of no-carrier-added p-[124I]iodo-L-phenylalanine and p-[131I]iodo-L-phenylalanine for nuclear medicine applications in malignant gliomas.
Israel I; Brandau W; Farmakis G; Samnick S
Appl Radiat Isot; 2008 Apr; 66(4):513-22. PubMed ID: 18024046
[TBL] [Abstract][Full Text] [Related]
17. Iodination and radiolabeling of alpha-allocryptopine with iodine-125.
Wei Y; Wei X; Wang Y; Liu X; Chu T; Hu S; Wang X
Appl Radiat Isot; 2005 Jan; 62(1):55-62. PubMed ID: 15498685
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and preliminary characterization of radioiodinated benzofuran-3-yl-(indol-3-yl)maleimide derivatives as potential SPECT imaging probes for the detection of glycogen synthase kinase-3β (GSK-3β) in the brain.
Ono M; Kitada A; Watanabe H; Miyazaki A; Kimura H; Saji H
J Labelled Comp Radiopharm; 2016 Jun; 59(8):317-21. PubMed ID: 27126914
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo investigation of matrix metalloproteinase expression in metastatic tumor models.
Sprague JE; Li WP; Liang K; Achilefu S; Anderson CJ
Nucl Med Biol; 2006 Feb; 33(2):227-37. PubMed ID: 16546677
[TBL] [Abstract][Full Text] [Related]
20. Comparative in vivo evaluation of technetium and iodine labels on an anti-HER2 affibody for single-photon imaging of HER2 expression in tumors.
Orlova A; Nilsson FY; Wikman M; Widström C; Ståhl S; Carlsson J; Tolmachev V
J Nucl Med; 2006 Mar; 47(3):512-9. PubMed ID: 16513621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
